Evidence map›Paper›PMID 35711759›Full record

ArticleFrontiers in microbiology2022

CABGen: A Web Application for the Bioinformatic Analysis of Bacterial Genomes.

Felicita Mabel Duré, Melise Chaves Silveira, Cláudio Marcos Rocha-de-Souza, Robson Souza Leão, Ivson Cassiano de Oliveira Santos, Rodolpho Mattos Albano, Elizabeth Andrade Marques, Ana Paula D'Alincourt Carvalho-Assef, Fabricio Alves Barbosa da Silva

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Harnessing interpretable deep learning to predict resistance inFrontiers in cellular and infection microbiology · 2026
    Article
  2. Article
  3. Advances in the detection of Drug-Resistant bacteria: current trends and innovations.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  4. Detection of ESBL-producingFrontiers in microbiology · 2025
    Article
  5. Genomic study ofFrontiers in microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Felicita Mabel DuréCentral Public Health Laboratory (LCSP), Ministry of Public Health and Social Welfare MSPyBS, Asunción, Paraguay.
Melise Chaves SilveiraHospital Infection Research Laboratory (LAPIH), Oswaldo Cruz Institute-Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
Cláudio Marcos Rocha-de-SouzaHospital Infection Research Laboratory (LAPIH), Oswaldo Cruz Institute-Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
Robson Souza LeãoDepartment of Biochemistry, Roberto de Alcântara Gomes Biology Institute, State University of Rio de Janeiro - UERJ, Rio de Janeiro, Brazil.
Ivson Cassiano de Oliveira SantosHospital Infection Research Laboratory (LAPIH), Oswaldo Cruz Institute-Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
Rodolpho Mattos AlbanoDepartment of Biochemistry, Roberto de Alcântara Gomes Biology Institute, State University of Rio de Janeiro - UERJ, Rio de Janeiro, Brazil.
Elizabeth Andrade MarquesDepartment of Biochemistry, Roberto de Alcântara Gomes Biology Institute, State University of Rio de Janeiro - UERJ, Rio de Janeiro, Brazil.
Ana Paula D'Alincourt Carvalho-AssefHospital Infection Research Laboratory (LAPIH), Oswaldo Cruz Institute-Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
Fabricio Alves Barbosa da SilvaScientific Computing Program-Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
Fundação Oswaldo Cruz · BRUniversidade do Estado do Rio de Janeiro · BRMinisterio de Salud Pública y Bienestar Social · PY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to recent developments in NGS technologies, genome sequencing is generating large volumes of new data containing a wealth of biological information. Understanding sequenced genomes in a biologically meaningful way and delineating their functional and metabolic landscapes is a first-level challenge. Considering the global antimicrobial resistance (AMR) problem, investments to expand surveillance and improve existing genome analysis technologies are pressing. In addition, the speed at which new genomic data is generated surpasses our capacity to analyze it with available bioinformatics methods, thus creating a need to develop new, user-friendly and comprehensive analytical tools. To this end, we propose a new web application, CABGen, developed with open-source software. CABGen allows storing, organizing, analyzing, and interpreting bioinformatics data in a friendly, scalable, easy-to-use environment and can process data from bacterial isolates of different species and origins. CABGen has three modules: Upload Sequences, Analyze Sequences, and Verify Results. Functionalities include coverage estimation, species identification,

Indexed as

antimicrobial resistancebacteriabioinformaticsgenomepipelineweb application

Identifiers

PMID35711759
PMCPMC9196194
OpenAlexW4281774160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.